GORDON CARL L bought ADRX

September 28, 2026 · Form 4 insider transaction

GORDON CARL L bought 588,235 shares of ADRX at $17.00 per share, a transaction worth $10.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
588,235
Price
$17.00
Total value
$10.00M
RoleDirector
CompanyADRX
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 28, 2026
Filing dateSeptember 30, 2026
Shares owned after588,235
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.; These securities are held directly by OrbiMed Genesis Master Fund, L.P. ("OrbiMed Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of OrbiMed Genesis. OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OrbiMed Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OrbiMed Genesis.; Each of the Reporting Person, OrbiMed Advisors, GP VII, Israel GP, Advisors Israel, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.

View the original Form 4 on SEC EDGAR